Currently, there is one main vaccine for malaria, called RTS,S, also known as Mosquirix.
Malaria Vaccine Details
- Name: RTS,S (also known as Mosquirix)
- Developer: GlaxoSmithKline (GSK) in partnership with the PATH Malaria Vaccine Initiative
- Target: Plasmodium falciparum parasite (the parasite that causes malaria)
- Transmission: Spread by anopheles mosquitoes.
- Availability: The vaccine is being implemented in several countries.
The RTS,S malaria vaccine (Mosquirix) is designed to help the body build immunity against the Plasmodium falciparum parasite which is responsible for malaria.